Human studies are available. Consider the trial phase, population, sample size, comparator, duration and whether findings have been replicated.
A curated starting point for exploring scientific publications and understanding what different kinds of evidence can — and cannot — tell us. This library links to public research records and publisher pages so readers can consult the original work.
Study design matters. A result in cells or animals is not equivalent to a controlled human trial, and a clinical trial result does not automatically establish the quality or status of any separately supplied material.
Human studies are available. Consider the trial phase, population, sample size, comparator, duration and whether findings have been replicated.
Evidence comes mainly from laboratory or animal models. These studies can explore mechanisms but cannot establish human benefit or safety.
Research describes biological pathways or molecular activity. A plausible mechanism is not proof of a useful clinical outcome.
Selected public records across peptide science, metabolic research and cellular biology. Each reference opens its original PubMed record; availability of full text depends on the publisher or repository.
A phase 3 randomised clinical study evaluating tirzepatide in adults with type 2 diabetes. Read the trial design, outcomes and limitations in the original record.
A phase 2 study describing a triple-hormone-receptor agonist in adults with obesity. The paper is an investigational-molecule study, not evidence about any commercial material.
A randomised clinical study examining tesamorelin and changes in visceral adipose tissue and liver fat in a defined clinical population.
Laboratory research examining copper-peptide effects on fibroblast-related cellular processes. In-vitro findings should not be presented as established clinical outcomes.
An experimental study involving cultured dermal papilla cells and ex-vivo human hair follicles. Model-based findings require further clinical evaluation.
A starting point for reviewing the preclinical literature and the substantial gap between experimental models and well-established human clinical evidence.
Research into NAD+ as a central redox cofactor and its role in cellular metabolism and NAD-dependent enzyme systems.
A large clinical study in acute ischaemic stroke. Review the primary paper and subsequent evidence assessments before drawing conclusions.
Scientific publications describe the specific compounds, formulations, populations and methods studied by their authors. They do not verify the identity, purity, sterility, concentration, regulatory status or suitability of any material offered by a separate supplier. This page is educational, not medical advice, and does not provide dosing, preparation or treatment instructions. Always consult qualified professionals and relevant UK regulatory information where appropriate.